INO logoINO
Inovio Pharmaceuticals Inc

92,670
Loading...
Loading...
News
all
press releases
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
Inovio stock surges 21% after the FDA gives green light to begin a rolling BLA for its RRP drug INO-3107, with plans to seek priority review.
Zacks·19d ago
News Placeholder
More News
News Placeholder
PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug
Precigen stock soars 144% in August after FDA approval of Papzimeos, the first treatment for adults with recurrent respiratory papillomatosis.
Zacks·22d ago
News Placeholder
Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates
Agenus (AGEN) delivered earnings and revenue surprises of -28.21% and +2.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.
Zacks·1mo ago
News Placeholder
Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline
Dianthus Therapeutics, Inc. (DNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?
Inovio (INO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·1mo ago
News Placeholder
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates
Zacks·4mo ago
News Placeholder
Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference
Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference Immune Response Data for INO-3107 to be Presented as a...
PR Newswire·7mo ago
News Placeholder
INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference PR Newswire PLYMOUTH...
PR Newswire·8mo ago
News Placeholder
INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments PR Newswire PLYMOUTH MEETING, Pa., Jan. 9, 2025...
PR Newswire·8mo ago

Latest INO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.